Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Myriad Genetics, |
RCV000000831 | SCV004045552 | pathogenic | Familial adenomatous polyposis 1 | 2023-05-01 | criteria provided, single submitter | clinical testing | This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation. |
Ambry Genetics | RCV005372222 | SCV006035105 | pathogenic | Hereditary cancer-predisposing syndrome | 2025-02-06 | criteria provided, single submitter | clinical testing | The c.1369delT pathogenic mutation, located in coding exon 10 of the APC gene, results from a deletion of one nucleotide at nucleotide position 1369, causing a translational frameshift with a predicted alternate stop codon (p.S457Hfs*10). This variant was reported in individual(s) with features consistent with APC-related familial adenomatous polyposis (FAP) (Ambry internal data). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |
OMIM | RCV000000831 | SCV000020981 | pathogenic | Familial adenomatous polyposis 1 | 1991-08-09 | no assertion criteria provided | literature only |